Susceptibility of clinical isolates of uropathogenic bacteria from Southwest Nigeria to antibiotics and extracts of Brachystegia eurycoma Harms (Leguminosae)
Abstract
Resistance of uropathogens to antibiotics has been on increase and responsible for increased mortality and morbidity among patients. Clinical isolates (22) of uropathogenic bacteria comprising Escherichia coli, Klebsiella
Pneumoniae, Proteus mirabilis and Staphylococcus aureus were tested for susceptibility to standard antibiotics and extracts of Brachystegia eurycoma. Methanolic extracts of leaves, stem and root barks of the plant were screened at 20mg/ml against the organisms using agar well diffusion method. Susceptibility of the isolates to plant extracts and standard antibiotics (amoxicillin, gentamicin, ofloxacin, chloramphenicol, tetracycline, augmentin, nalidixic acid, nitrofurantoin, erythromycin and cotrimoxazole) was done using agar disc diffusion methods respectively. Minimum Inhibitory Concentrations (MICs) of the extracts were determined by agar-dilution method on some of the uropathogens. Ofloxacin was the most active against E. coli, K. pneumoniae and P. mirabilis while gentamicin and chloramphenicol were the most active on S. aureus. The plant’s extracts showed good activity on most of the uropathogens, even on the multidrug resistant (MDR) isolates of S. aureus and P. mirabilis. The MIC of B. eurycoma extracts on E. coli, K. pneumonia and S, aureus varied from 0.06 to 1.0mg/ml. This study showed that MDR uropathogens were still prevalent in Southwest Nigeria and that extracts of B. eurycoma contains bioactive compounds having good antibacterial activity, especially on the MDR clinical isolates. The overall results indicated varied patterns of sensitivity and resistance to antibiotics and extracts, warranting judicious and rational use of antibiotics in the routine treatment of UTI to prevent recurrence and development of resistant strains.
Keywords: Uropathogens; Resistance; Antibiotics; Brachystegia eurycoma extracts; MIC.
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
